Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trialEvanthia T. Roussos Torres, Roisín M. Connolly|Nature Cancer|2024Cited by 46
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T. Roussos Torres, Roisín M. Connolly|Clinical Cancer Research|2021Cited by 35
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancerAaron G. Baugh, Evanthia T. Roussos Torres|Clinical & Experimental Metastasis|2024Cited by 6
A class act: HDAC1- <i>Malat1</i> regulates MDSC apoptosis and cell cycling to decrease suppression of T cellsAaron G. Baugh, Evanthia T. Roussos Torres|bioRxiv (Cold Spring Harbor Laboratory)|2026Cited by 1
Mimicking the breast metastatic microenvironment: characterization of a novel syngeneic model of HER2 <sup>+</sup> breast cancerAaron G. Baugh, Evanthia T. Roussos Torres|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0